- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 30/04 - Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
Patent holdings for IPC class C40B 30/04
Total number of patents in this class: 2184
10-year publication summary
|
143
|
139
|
137
|
161
|
112
|
99
|
103
|
90
|
76
|
52
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Prognosys Biosciences, Inc. | 106 |
55 |
| The Regents of the University of California | 20987 |
50 |
| President and Fellows of Harvard College | 6119 |
34 |
| The Board of Trustees of the Leland Stanford Junior University | 6734 |
28 |
| University Health Network | 1073 |
27 |
| The Johns Hopkins University | 5958 |
23 |
| 10X Genomics, Inc. | 1394 |
22 |
| Massachusetts Institute of Technology | 10324 |
21 |
| Bioatla, Inc. | 117 |
20 |
| Bio-Rad Laboratories, Inc. | 1612 |
19 |
| The University of British Columbia | 1565 |
17 |
| Chugai Seiyaku Kabushiki Kaisha | 1433 |
16 |
| Arizona Board of Regents on behalf of Arizona State University | 3015 |
15 |
| The Broad Institute, Inc. | 1998 |
14 |
| The Governing Council of The University of Toronto, | 1555 |
14 |
| Vibrant Holdings, LLC | 80 |
14 |
| Bristol-myers Squibb Company | 4751 |
13 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 268 |
13 |
| The Trustees of Columbia University in the City of New York | 3666 |
12 |
| Adimab, LLC | 157 |
12 |
| Other owners | 1745 |